REPORT ID 6729

Global Traumatic Brain Injury Therapeutics Market Professional Survey Report 2017

Publish Date
26-Dec-17
Pages
119
Format
Electronic (PDF)

This report studies Traumatic Brain Injury Therapeutics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    SFC Fluidics LLC
    Banayan Biomarkers Inc.
    BHR Pharma LLC
    Cerora Inc.
    ElMindA Ltd.
    Grace Laboratories LLC
    KeyNeurotek Pharmaceuticals AG
    Luoxis Diagnostics
    Neuro Assessment Systems
    Neurovive Pharmaceuticals AB
    Oxygen Biotherapeutics Inc.
    Phlogistix LLC
    Neurohealing Pharmaceuticals
    Neuren Pharmaceuticals Ltd.
    Remedy Pharmaceuticals Inc.
    Biodirection Inc.
    Brainscope Company Inc.
    TEVA Pharmaceutical Industries Ltd.
    Vasopharm

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Acetylcholinesterase Inhibitors
    Erythropoietin
    Growth Hormone
    Stem Cells
    Others

By Application, the market can be split into
    Focal TBI
    Open TBI
    Closed TBI
    Diffuse TBI
    Primary TBI
    Others

By Regions, this report covers (we can add the regions/countries as you want)
    North America
    China
    Europe
    Southeast Asia
    Japan
    India

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Traumatic Brain Injury Therapeutics Market Professional Survey Report 2017
1 Industry Overview of Traumatic Brain Injury Therapeutics
    1.1 Definition and Specifications of Traumatic Brain Injury Therapeutics
        1.1.1 Definition of Traumatic Brain Injury Therapeutics
        1.1.2 Specifications of Traumatic Brain Injury Therapeutics
    1.2 Classification of Traumatic Brain Injury Therapeutics
        1.2.1 Acetylcholinesterase Inhibitors
        1.2.2 Erythropoietin
        1.2.3 Growth Hormone
        1.2.4 Stem Cells
        1.2.5 Others
    1.3 Applications of Traumatic Brain Injury Therapeutics
        1.3.1 Focal TBI
        1.3.2 Open TBI
        1.3.3 Closed TBI
        1.3.4 Diffuse TBI
        1.3.5 Primary TBI
        1.3.6 Others
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 China
        1.4.3 Europe
        1.4.4 Southeast Asia
        1.4.5 Japan
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Traumatic Brain Injury Therapeutics
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Traumatic Brain Injury Therapeutics
    2.3 Manufacturing Process Analysis of Traumatic Brain Injury Therapeutics
    2.4 Industry Chain Structure of Traumatic Brain Injury Therapeutics

3 Technical Data and Manufacturing Plants Analysis of Traumatic Brain Injury Therapeutics
    3.1 Capacity and Commercial Production Date of Global Traumatic Brain Injury Therapeutics Major Manufacturers in 2016
    3.2 Manufacturing Plants Distribution of Global Traumatic Brain Injury Therapeutics Major Manufacturers in 2016
    3.3 R&D Status and Technology Source of Global Traumatic Brain Injury Therapeutics Major Manufacturers in 2016
    3.4 Raw Materials Sources Analysis of Global Traumatic Brain Injury Therapeutics Major Manufacturers in 2016

4 Global Traumatic Brain Injury Therapeutics Overall Market Overview
    4.1 2012-2017E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2012-2017E Global Traumatic Brain Injury Therapeutics Capacity and Growth Rate Analysis
        4.2.2 2016 Traumatic Brain Injury Therapeutics Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2012-2017E Global Traumatic Brain Injury Therapeutics Sales and Growth Rate Analysis
        4.3.2 2016 Traumatic Brain Injury Therapeutics Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2012-2017E Global Traumatic Brain Injury Therapeutics Sales Price
        4.4.2 2016 Traumatic Brain Injury Therapeutics Sales Price Analysis (Company Segment)

5 Traumatic Brain Injury Therapeutics Regional Market Analysis
    5.1 North America Traumatic Brain Injury Therapeutics Market Analysis
        5.1.1 North America Traumatic Brain Injury Therapeutics Market Overview
        5.1.2 North America 2012-2017E Traumatic Brain Injury Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2012-2017E Traumatic Brain Injury Therapeutics Sales Price Analysis
        5.1.4 North America 2016 Traumatic Brain Injury Therapeutics Market Share Analysis
    5.2 China Traumatic Brain Injury Therapeutics Market Analysis
        5.2.1 China Traumatic Brain Injury Therapeutics Market Overview
        5.2.2 China 2012-2017E Traumatic Brain Injury Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 China 2012-2017E Traumatic Brain Injury Therapeutics Sales Price Analysis
        5.2.4 China 2016 Traumatic Brain Injury Therapeutics Market Share Analysis
    5.3 Europe Traumatic Brain Injury Therapeutics Market Analysis
        5.3.1 Europe Traumatic Brain Injury Therapeutics Market Overview
        5.3.2 Europe 2012-2017E Traumatic Brain Injury Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 Europe 2012-2017E Traumatic Brain Injury Therapeutics Sales Price Analysis
        5.3.4 Europe 2016 Traumatic Brain Injury Therapeutics Market Share Analysis
    5.4 Southeast Asia Traumatic Brain Injury Therapeutics Market Analysis
        5.4.1 Southeast Asia Traumatic Brain Injury Therapeutics Market Overview
        5.4.2 Southeast Asia 2012-2017E Traumatic Brain Injury Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Southeast Asia 2012-2017E Traumatic Brain Injury Therapeutics Sales Price Analysis
        5.4.4 Southeast Asia 2016 Traumatic Brain Injury Therapeutics Market Share Analysis
    5.5 Japan Traumatic Brain Injury Therapeutics Market Analysis
        5.5.1 Japan Traumatic Brain Injury Therapeutics Market Overview
        5.5.2 Japan 2012-2017E Traumatic Brain Injury Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Japan 2012-2017E Traumatic Brain Injury Therapeutics Sales Price Analysis
        5.5.4 Japan 2016 Traumatic Brain Injury Therapeutics Market Share Analysis
    5.6 India Traumatic Brain Injury Therapeutics Market Analysis
        5.6.1 India Traumatic Brain Injury Therapeutics Market Overview
        5.6.2 India 2012-2017E Traumatic Brain Injury Therapeutics Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2012-2017E Traumatic Brain Injury Therapeutics Sales Price Analysis
        5.6.4 India 2016 Traumatic Brain Injury Therapeutics Market Share Analysis

6 Global 2012-2017E Traumatic Brain Injury Therapeutics Segment Market Analysis (by Type)
    6.1 Global 2012-2017E Traumatic Brain Injury Therapeutics Sales by Type
    6.2 Different Types of Traumatic Brain Injury Therapeutics Product Interview Price Analysis
    6.3 Different Types of Traumatic Brain Injury Therapeutics Product Driving Factors Analysis
        6.3.1 Acetylcholinesterase Inhibitors of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        6.3.2 Erythropoietin of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        6.3.3 Growth Hormone of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        6.3.4 Stem Cells of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        6.3.5 Others of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis

7 Global 2012-2017E Traumatic Brain Injury Therapeutics Segment Market Analysis (by Application)
    7.1 Global 2012-2017E Traumatic Brain Injury Therapeutics Consumption by Application
    7.2 Different Application of Traumatic Brain Injury Therapeutics Product Interview Price Analysis
    7.3 Different Application of Traumatic Brain Injury Therapeutics Product Driving Factors Analysis
        7.3.1 Focal TBI of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        7.3.2 Open TBI of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        7.3.3 Closed TBI of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        7.3.4 Diffuse TBI of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        7.3.5 Primary TBI of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis
        7.3.6 Others of Traumatic Brain Injury Therapeutics Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Traumatic Brain Injury Therapeutics
    8.1 SFC Fluidics LLC
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 SFC Fluidics LLC 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 SFC Fluidics LLC 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.2 Banayan Biomarkers Inc.
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Banayan Biomarkers Inc. 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Banayan Biomarkers Inc. 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.3 BHR Pharma LLC
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 BHR Pharma LLC 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 BHR Pharma LLC 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.4 Cerora Inc.
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Cerora Inc. 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Cerora Inc. 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.5 ElMindA Ltd.
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 ElMindA Ltd. 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 ElMindA Ltd. 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.6 Grace Laboratories LLC
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Grace Laboratories LLC 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Grace Laboratories LLC 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.7 KeyNeurotek Pharmaceuticals AG
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 KeyNeurotek Pharmaceuticals AG 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 KeyNeurotek Pharmaceuticals AG 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.8 Luoxis Diagnostics
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Luoxis Diagnostics 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Luoxis Diagnostics 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.9 Neuro Assessment Systems
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Neuro Assessment Systems 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Neuro Assessment Systems 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.10 Neurovive Pharmaceuticals AB
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Neurovive Pharmaceuticals AB 2016 Traumatic Brain Injury Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Neurovive Pharmaceuticals AB 2016 Traumatic Brain Injury Therapeutics Business Region Distribution Analysis
    8.11 Oxygen Biotherapeutics Inc.
    8.12 Phlogistix LLC
    8.13 Neurohealing Pharmaceuticals
    8.14 Neuren Pharmaceuticals Ltd.
    8.15 Remedy Pharmaceuticals Inc.
    8.16 Biodirection Inc.
    8.17 Brainscope Company Inc.
    8.18 TEVA Pharmaceutical Industries Ltd.
    8.19 Vasopharm

9 Development Trend of Analysis of Traumatic Brain Injury Therapeutics Market
    9.1 Global Traumatic Brain Injury Therapeutics Market Trend Analysis
        9.1.1 Global 2017-2022 Traumatic Brain Injury Therapeutics Market Size (Volume and Value) Forecast
        9.1.2 Global 2017-2022 Traumatic Brain Injury Therapeutics Sales Price Forecast
    9.2 Traumatic Brain Injury Therapeutics Regional Market Trend
        9.2.1 North America 2017-2022 Traumatic Brain Injury Therapeutics Consumption Forecast
        9.2.2 China 2017-2022 Traumatic Brain Injury Therapeutics Consumption Forecast
        9.2.3 Europe 2017-2022 Traumatic Brain Injury Therapeutics Consumption Forecast
        9.2.4 Southeast Asia 2017-2022 Traumatic Brain Injury Therapeutics Consumption Forecast
        9.2.5 Japan 2017-2022 Traumatic Brain Injury Therapeutics Consumption Forecast
        9.2.6 India 2017-2022 Traumatic Brain Injury Therapeutics Consumption Forecast
    9.3 Traumatic Brain Injury Therapeutics Market Trend (Product Type)
    9.4 Traumatic Brain Injury Therapeutics Market Trend (Application)

10 Traumatic Brain Injury Therapeutics Marketing Type Analysis
    10.1 Traumatic Brain Injury Therapeutics Regional Marketing Type Analysis
    10.2 Traumatic Brain Injury Therapeutics International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Traumatic Brain Injury Therapeutics by Region
    10.4 Traumatic Brain Injury Therapeutics Supply Chain Analysis

11 Consumers Analysis of Traumatic Brain Injury Therapeutics
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Traumatic Brain Injury Therapeutics Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source